Valuation: Vystar Corporation

Market Cap 2.91M 2.54M 2.34M 2.16M 4.07M 280M 4.16M 28M 11.01M 137M 10.91M 10.67M 472M P/E 2024
0.63x
P/E 2025 -0.58x
Enterprise Value 3.98M 3.48M 3.21M 2.96M 5.58M 384M 5.7M 38.39M 15.1M 188M 14.96M 14.63M 647M EV / Sales 2024
13.1x
EV / Sales 2025 39.9x
Free-Float
93.05%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 58 21/12/2023
Director TitleAgeSince
Director/Board Member 58 17/12/2017
Chairman 46 14/02/2018
Director/Board Member 71 25/01/2021
Change 5-day change 1-year change 3-year change Capi.($)
-1.03%-4.67% - - 2.91M
-2.26%+2.34%+5.80%+42.35% 97.28B
-3.31%+1.35%-7.50%+47.97% 69.07B
-2.21%+0.79%-9.27% - 23.14B
+19.69%+1.34%+34.68%+84.32% 16.41B
-1.12%+1.57%-17.21%-8.60% 8.31B
-1.82%-8.78%+5.34%0.00% 6.53B
-4.44%-4.16%+53.02%+57.43% 6.01B
-8.96%-20.43%+16.75%+41.31% 3.95B
-3.23%-1.24%+33.56%-16.55% 3.06B
Average -2.61%-0.50%+12.80%+31.03% 25.97B
Weighted average by Cap. -1.81%+2.79%+3.34%+43.69%

Financials

2024 2025
Net sales 136K 119K 110K 101K 190K 13.09M 195K 1.31M 515K 6.41M 511K 499K 22.08M 54.82K 47.91K 44.21K 40.75K 76.8K 5.28M 78.51K 528K 208K 2.59M 206K 201K 8.9M
Net income 760K 664K 612K 565K 1.06M 73.14M 1.09M 7.32M 2.88M 35.82M 2.85M 2.79M 123M -1.53M -1.34M -1.24M -1.14M -2.15M -148M -2.19M -14.76M -5.81M -72.24M -5.75M -5.63M -249M
Net Debt 1.15M 1.01M 928K 856K 1.61M 111M 1.65M 11.09M 4.36M 54.29M 4.32M 4.23M 187M 1.08M 942K 869K 801K 1.51M 104M 1.54M 10.39M 4.09M 50.84M 4.05M 3.96M 175M
Logo Vystar Corporation
Vystar Corporation is the owner and manufacturer of multiple brands of eco-friendly products for the home, office and medical sectors. The Company is focused on three main brands: Vytex, RXAIR, and Fluid Energy Conversion (FEC). The Company uses patented technology to produce a line of air purifiers, which destroy viruses and bacteria through the use of ultraviolet light. It is also the creator and owner of Vytex Natural Rubber Latex (NRL), being used primarily in toppers and in various bedding products. RxAir is the manufacturer of air purification systems in the world and a developer, manufacturer and distributor of biotechnology products targeting the indoor air quality (IAQ) industry sector. RxAir’s products include the RxAir purification system for the home as well as lines of hospital-grade HEPA filtration products. All of its products are Food and Drug Administration (FDA) certified as Class II medical devices and kill germs, viruses and bacteria.
Employees
-